Plant Variety Rights

(PVRs)

Experts in IP Protection for Plant Variety Inventions


Improvement of crop and ornamental species by genetic modification or modern breeding techniques remains a significant area of innovation. A number of IP rights may be suitable for protecting plant inventions, including patents, trade marks, plant Variety Rights (PVRs) and entry on the national list or common catalogue. Our experienced IP specialists are well placed to assist our clients in this area, having a wealth of practical experience.

In Europe, individual plant varieties that are distinct, uniform and stable can be protected either nationally or at European Community level. Separately, European and national patents can be obtained for plants and plant-related inventions which are not restricted to plant varieties per se, although certain plant breeding methods and plants obtained by those methods are excluded from patentability.  Despite the EU’s strict policies on growing genetically modified crops and uncertainty surrounding the use of genetic resources in plant breeding, there is considerable commercial interest in these technical areas and in IP protection for the output of biotech research and classical breeding programs.

Our expert IP team is led by Frances Salisbury, who has a PhD in plant molecular genetics. An expert in this field Frances has completed the official World Intellectual Property Organisation (WIPO) course on Plant Variety Protection under the UPOV Convention.

Read our Plant Variety Rights Law and Practice guide.

Read our blogs

Beyond PROTACs and molecular glues: where next for heterobifunctional drug discovery?

Beyond PROTACs and molecular glues: where next for heterobifunctional drug discovery?

by Annabel Cardno

A broader heterobifunctional tool emerges Targeted protein degradation has rapidly progressed from a conceptual curiosity to one of the most closely watched areas in drug discovery. As discussed in ...

Global considerations for innovators in microbial biostimulants and biocontrol agents

Global considerations for innovators in microbial biostimulants and biocontrol agents

by Ben Tolley

Our recent analysis found that global patent activity in microbial biostimulants and biocontrol agents is surging, with strong growth in both patent applications and granted patents. For a detailed ...

EPO decision T 0655/24: inventive step and the unpredictability of antibody mutations

EPO decision T 0655/24: inventive step and the unpredictability of antibody mutations

by Chris Denison

This is the final post in a series on decision T 0655/24 and its implications for antibody practice at the EPO. In the first post, Chris discussed the Board’s strict approach to post-filing evidence ...

EU NGT Regulation Approved: A Step Towards Innovation

EU NGT Regulation Approved: A Step Towards Innovation

by Louise Atkins

The EU’s long‑awaited regulation on New Genomic Techniques (NGTs) has now cleared its final legislative hurdle, with the European Parliament voting to approve the agreed framework, rejecting ...

Molecular Glue Degraders (MGDs): what they are, how they work and key IP Issues

Molecular Glue Degraders (MGDs): what they are, how they work and key IP Issues

by Tim Nash

Molecular glue degraders (MGDs) are small molecules that induce or stabilise protein–protein interactions, often by recruiting an E3 ligase to a target protein and triggering its ubiquitination and ...

Ageing as a disease: Groundbreaking or Ground-Shaking?

Ageing as a disease: Groundbreaking or Ground-Shaking?

by Emily Garnett

As a species, humans have long been preoccupied with living longer and healthier lives. However, prior to the advent of modern medicine, any real prospect of fulfilling these ambitions existed more ...

ME Forward Masthead White 2